Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Line Items]
Capitalized research and development domestic expenses amortization period	5 years
Capitalized research and development foreign expenses amortization period	15 years
Change in valuation allowance	$ 50,728,000	$ 19,090,000
Percentage of corporations stock owned by stockholders to determine ownership change	5.00%
Maximum threshold percentage increases over a three year period of corporations stock owned by stockholders for ownership change	50.00%
Uncertain tax positions	$ 0
Description of income tax examination	The Company’s Federal and State tax returns for all years, 2015 through 2021, remain subject to examination by taxing authorities due to the tax attribute carryforwards.
Domestic Tax Authority
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	$ 159,000,000.0
Operating loss carryforwards expiration year	2035
Domestic Tax Authority | Tax Period 2035
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	$ 6,300,000
Domestic Tax Authority | Indefinitely Carryforward
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	152,700,000
State and Local Jurisdiction
Income Tax Disclosure [Line Items]
Net operating loss carryforwards	$ 160,600,000
Operating loss carryforwards expiration year	2035
IRC Section 174
Income Tax Disclosure [Line Items]
Change in valuation allowance	$ 51,100,000	$ 19,100,000
Research Tax Credit Carryforward | Domestic Tax Authority
Income Tax Disclosure [Line Items]
Tax credit carryforward amount	$ 1,900,000
Operating loss carryforwards expiration year	2038
Minimum
Income Tax Disclosure [Line Items]
Income tax examination year under examination	2015
Maximum
Income Tax Disclosure [Line Items]
Income tax examination year under examination	2021